University of Michigan

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Michigan sits in the top decile of US sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count).

1,327 total trials 179 currently recruiting 971 completed early-phase tilt top decile by trial count

University of Michigan: 1,327 sponsored US clinical trials, 179 recruiting.

University of Michigan sponsors 1,327 registered US clinical trials on ClinicalTrials.gov, 179 of them currently recruiting, and 971 completed. 94 of these trials are in Phase 3-4 (later-stage) and 159 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 15 trials.

Top-decile sponsor footprint

University of Michigan ranks in the top decile of sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 64/100

971 of 1,083 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,327 total, page 7 of 27

COMPLETED Phase 4

The Immunologic Effects of Dupilumab in the Treatment of Dermal Hypersensitivity Reaction

NCT06012448

COMPLETED NA

Pilot Feasibility Study for HypoPals, a Mobile Health Program for Improving Hypoglycemia Management.

NCT05916131

COMPLETED NA

A Study to Improve Physician-Youth Communication and Medical Decision Making

NCT05835063

COMPLETED NA

Family Teams: A Study to Promote Team Collaboration in Family Medicine Clinics

NCT06011239

COMPLETED NA

A Pilot Randomized Controlled Trial: CoINTEGRATE

NCT05732285

COMPLETED NA

Tele-video to Improve Daily Activity

NCT06007664

TERMINATED NA

Transcutaneous Vibro-Acoustic Therapy in Parkinson Disease

NCT05962476

COMPLETED NA

MIVetsCan: Can-Coach Trial (Phase 1)

NCT06320470

COMPLETED Phase 1

The Breakfast Study

NCT05986097

COMPLETED NA

Mood Lifters for Undergraduates

NCT05684120

COMPLETED NA

What is the Potential Impact of Reviewing Post-procedure Images With Patients Following Interventional Spine Procedures.

NCT05884684

TERMINATED NA

Metacognitive Self Control and Job Interview Training

NCT05966831

COMPLETED NA

Effects of Exercise Training and Ketone Ester on Muscle Strength and Cardiovascular Response in Parkinson's Disease

NCT05948956

COMPLETED Phase 3

The Impact of an Adaptive Patient-centered Web Application on Medication Optimization in HFrEF Patients

NCT05858320

COMPLETED NA

An Online Evaluation of Work Chat

NCT05949086

COMPLETED Phase 3

LiveSMART Trial to Prevent Falls in Patients With Cirrhosis

NCT05794555

COMPLETED NA

Building a Multidisciplinary Research Program to Address Hypertension Disparities: Exploring the Neurocognitive Mechanisms of a Self-Management Intervention for African American Women

NCT04266704

COMPLETED NA

Self-regulation for Older Adults With Asthma Through Remote Education

NCT05722834

COMPLETED NA

EDUCATE-C: Education on Cirrhosis -- Assessing Text vs Video

NCT07216807

COMPLETED NA

Feel the Move: A Micro-Randomized Trial of a Text-Based Expectation-Setting Intervention to Increase Physical Activity

NCT05582369

COMPLETED NA

Broccoli Sprouts for Mild Ulcerative Colitis

NCT05507931

COMPLETED NA

Predicting Peanut Anaphylaxis and Reducing Epinephrine

NCT05696236

COMPLETED NA

A Patient-facing Tool to Reduce Opioid-Psychotropic Polypharmacy in People Living With Dementia (PLWD)

NCT05628181

COMPLETED NA

Cognitive Training Video Game to Target Subclinical Depressive Symptoms in Youth

NCT05697627

TERMINATED NA

Comprehensive Cognitive and Affective Intervention for Mild Cognitive Impairment (MCI) for Foreign-Born Arab Americans

NCT05854290

COMPLETED NA

Treatment of Gingival Recession Defects Using Platelet-Rich Fibrin With an Allogenic Dermal Matrix

NCT05819515

COMPLETED NA

Toward Thriving: A Set of Reflective Tools to Empower Chronic Pain Patients and Help Them Envision a Personal Path to Thriving.

NCT05847881

COMPLETED NA

Bipolar Transcranial Alternating Current Stimulation (tACS)

NCT05480124

COMPLETED NA

Oral Health Recovery Group

NCT05864027

COMPLETED NA

Evaluating the Efficacy of the Mediterranean Diet to the Low- Fermentable, Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAP) Diet in Treating Irritable Bowel Syndrome(IBS)

NCT05807919

COMPLETED NA

EMBRace With Grandparents

NCT04096378

COMPLETED Early Phase 1

Fluoride in Saliva After Use of Fluoride Toothpastes Followed by Fluoride Mouthrinses

NCT05601154

TERMINATED NA

Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Ketones

NCT05778695

COMPLETED NA

Post Anesthesia Care Unit (PACU) Weighted Blanket Study

NCT05632640

COMPLETED Phase 4

Comparison of a Morphomic-Based to the Standard-of-Care-Based Cefazolin Dose for Antimicrobial Prophylaxis

NCT06005168

TERMINATED NA

MENDD Tolerance Assessment Study

NCT06185088

COMPLETED NA

Connecting National Guard Service Members Through Education in Crisis Line Facilitation Training

NCT05405231

COMPLETED Phase 2

Erector Spinae Plane Block for Uncomplicated Renal Colic

NCT05625802

COMPLETED NA

Supporting Laypeople Addressing Prehospital Hemorrhage Study

NCT05812352

COMPLETED NA

Empower@Home:Connected - Feasibility and Preliminary Effect Study

NCT05732740

COMPLETED NA

Enhancing the Cardiovascular Safety of Hemodialysis Care (Dialysafe)

NCT03171545

COMPLETED

Evaluating Student Wellness Using a Blended Approach of the Roadmap mHealth App Plus Wellness Coaching

NCT05736445

COMPLETED NA

The Preliminary Effects of Empower@Home

NCT05593276

COMPLETED NA

Operant Conditioning After ACL Reconstruction

NCT05519345

COMPLETED NA

Evaluation of the Effectiveness of an Amnion-chorion Membrane for Alveolar Ridge Preservation

NCT05592158

COMPLETED NA

Home-based Therapeutic Drug Monitoring in Kidney Transplantation

NCT05005221

COMPLETED NA

Work Chat: An Interactive Virtual Workday

NCT05565482

COMPLETED

Diabetic Foot Ulcers Microbiome and Pathogen Identification

NCT05556954

COMPLETED NA

Development of a Multifunctional Rehabilitation Device for Persons With Parkinson's Disease

NCT05586490

COMPLETED NA

Anticoagulation With Enhanced Gastrointestinal Safety

NCT05563714

← Previous Page 7 of 27 Next →

Phase Distribution

PhaseTrial count
Phase 1 79
Phase 2 80
Phase 3 25
Phase 4 69

What is open in the University of Michigan pipeline

179 recruiting of 1,327 indexed (13% open); 971 completed (73%).

Phase mix: 94 late (III/IV) vs 159 early (I/II) (early-phase heavy).

Top condition: Depression (15 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Michigan: open-pipeline peers nationwide

Peers matched on 1,327 registered trials and 13% open enrollment, not the therapeutic-area sidebar.

University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 0%5%10%15%20%25% Total trials Recruiting share University of MichiganEli Lilly and CompanyGlaxoSmithKlineAstraZenecaUniversity of Colorado, DenverWayne State UniversityCase Comprehensive Cancer CenterAlbany Medical CollegeTaiho Oncology
University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,327 trials (± recruiting share)

Sponsors near 13% open enrollment (± trial volume)

What to do with this University of Michigan page

1,327 registered trials is a research-attention snapshot, not an endorsement of University of Michigan or any single study.

  • 179 of University of Michigan's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition University of Michigan studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Michigan pipeline card: 1,327 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.